On April 12, 2023, Creative Medical Technology Holdings Inc. (CELZ) witnessed a significant surge in their shares, which rose by over 70%. The reason behind this sudden increase was the announcement made by the company regarding the one-year follow-up data of CELZ-001. This treatment has shown significant efficacy in treating patients with spinal cord injuries. Creative Medical Technology is a renowned biotechnology company that focuses on regenerative medicine, explicitly using adult stem cell treatments to treat immunology, urology, orthopedics, and neurology. The companys patented procedure, StemSpine, treats spinal cord injuries.

The one-year follow-up data of CELZ-001 revealed that it was highly effective in treating patients with spinal cord injuries. The treatment resulted in significant improvements in motor, sensory, and bladder functions. The StemSpine procedure involves using amniotic fluid-derived stem cells for therapeutic applications. The companys core activity is stem cell research and the development of applications for treating male and female sexual dysfunction, infertility, miscarriages, and related issues.

CELZ stock has witnessed high volatility over the past year, with weekly volatility that has increased from 20% to 32%. The company has a market cap of less than $100 million and trades less than 100,000 shares daily. It is important to note that penny stocks are frequently the playground for scam artists.

On April 12, 2023, CELZ stock opened at $0.49 and had a days range of $0.44 to $0.53 with a volume of 140,113 shares traded. The average volume for the past three months was 1,832,378 shares. The market capitalization was unavailable, and the earnings growth for the past year was -112.58%. The revenue growth for the past year was +0.96%. CELZ had no P/E ratio and no price/book ratio data. The price/sales ratio was 47.02. CELZ is a health technology company in the medical specialties industry, with its corporate headquarters located in Phoenix, Arizona. CELZ is expected to report its subsequent earnings on May 31, 2023, with an EPS forecast for this quarter of -$0.10. The annual revenue for the past year was $88.6K, with a yearly profit of -$10.1M. The net profit margin was -11,449.26%.

On April 12, Creative Medical Technology Holdings Inc (CELZ) saw a significant increase in its stock performance. This was because the one analyst offering 12-month price forecasts for the company had a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. This represented a +1,328.57% increase from the last price of 0.49.

Link:
Creative Medical Technology Holdings Inc Witnesses Significant ... - Best Stocks